Correlation Between Cytodyn and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cytodyn and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytodyn and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytodyn and Denali Therapeutics, you can compare the effects of market volatilities on Cytodyn and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytodyn with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytodyn and Denali Therapeutics.
Diversification Opportunities for Cytodyn and Denali Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cytodyn and Denali is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Cytodyn and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Cytodyn is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytodyn are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Cytodyn i.e., Cytodyn and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Cytodyn and Denali Therapeutics
Given the investment horizon of 90 days Cytodyn is expected to under-perform the Denali Therapeutics. In addition to that, Cytodyn is 1.31 times more volatile than Denali Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. Denali Therapeutics is currently generating about -0.01 per unit of volatility. If you would invest 2,525 in Denali Therapeutics on September 6, 2024 and sell it today you would lose (155.00) from holding Denali Therapeutics or give up 6.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 98.44% |
Values | Daily Returns |
Cytodyn vs. Denali Therapeutics
Performance |
Timeline |
Cytodyn |
Denali Therapeutics |
Cytodyn and Denali Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cytodyn and Denali Therapeutics
The main advantage of trading using opposite Cytodyn and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytodyn position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.Cytodyn vs. Madrigal Pharmaceuticals | Cytodyn vs. Scpharmaceuticals | Cytodyn vs. Akero Therapeutics | Cytodyn vs. Cardiff Oncology |
Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |